To ask the Secretary of State for Health what estimate he has made of the likely number of vCJD blood transfusion transfer cases over the next two years.

To ask the Secretary of State for Health what estimate he has made of the likely number of vCJD blood transfusion transfer cases over the next two years.

To ask the Secretary of State for Health what studies have been carried out on prion removal of blood filters in the UK; and if he will make a statement.

To ask the Secretary of State for Health what studies have been carried out on prion removal of blood filters in the UK; and if he will make a statement.

To ask the Secretary of State for Health if he will make it his policy to make the use of prion removal blood filters mandatory in the UK should the tests on prion removal blood filters in blood transfusions in Ireland prove successful.

To ask the Secretary of State for Health if he will make it his policy to make the use of prion removal blood filters mandatory in the UK should the tests on prion removal blood filters in blood transfusions in Ireland prove successful.

To ask the Secretary of State for Health how many cases of vCJD have been recorded in the UK as a result of blood transfusions.

To ask the Secretary of State for Health how many cases of vCJD have been recorded in the UK as a result of blood transfusions.

To ask the Secretary of State for Health (1) on what dates blood donations were made to the UK Blood Service by UK blood donors who later developed vCJD; and if he will make a statement;

To ask the Secretary of State for Health (1) on what dates blood donations were made to the UK Blood Service by UK blood donors who later developed vCJD; and if he will make a statement;

(2) how many UK blood donors have developed vCJD after donating blood to the UK Blood Service; and if he will make a statement.

(2) how many UK blood donors have developed vCJD after donating blood to the UK Blood Service; and if he will make a statement.

To ask the Secretary of State for Health pursuant to the answer of 12 June 2007, Official Report, column 1008W, on vCJD, what the name is of each prototype vCJD assay that is being evaluated; which body is carrying out each evaluation; what the purpose is of each evaluation; on...

To ask the Secretary of State for Health pursuant to the answer of 12 June 2007, Official Report, column 1008W, on vCJD, what the name is of each prototype vCJD assay that is being evaluated; which body is carrying out each evaluation; what the purpose is of each evaluation; on...

To ask the Secretary of State for Health pursuant to the answer of 14 June 2007 to question 142988, what the batch numbers were that were provided to NHS trusts, primary care trusts and to the UK Haemophilia Centre Doctors' Organisation.

To ask the Secretary of State for Health pursuant to the answer of 14 June 2007 to question 142988, what the batch numbers were that were provided to NHS trusts, primary care trusts and to the UK Haemophilia Centre Doctors' Organisation.

To ask the Secretary of State for Health how many blood samples from haemophiliacs have been made available to the National Institute for Biological Standards and Control for research into prototype vCJD blood tests; on what dates such samples were made available; and if she will make a statement.

To ask the Secretary of State for Health how many blood samples from haemophiliacs have been made available to the National Institute for Biological Standards and Control for research into prototype vCJD blood tests; on what dates such samples were made available; and if she will make a statement.

To ask the Secretary of State for Health how many samples of blood from haemophiliacs are being used in research to test for vCJD; and if she will make a statement.

To ask the Secretary of State for Health how many samples of blood from haemophiliacs are being used in research to test for vCJD; and if she will make a statement.

To ask the Secretary of State for Health if she will list the batches of blood products administered to patients in the UK that are known to be at risk from vCJD contamination; and if she will make a statement.

To ask the Secretary of State for Health if she will list the batches of blood products administered to patients in the UK that are known to be at risk from vCJD contamination; and if she will make a statement.

asked Her Majesty's Government:What is the average cost of providing a blood transfusion to an adult patient in the National Health Service; and what cost increase is expected when prion screening is introduced.

asked Her Majesty's Government:What is the average cost of providing a blood transfusion to an adult patient in the National Health Service; and what cost increase is expected when prion screening is introduced.

To ask the Secretary of State for Health what steps have been taken to inform those who received blood known to be at risk of variant Creutzfeldt-Jakob Disease (vCJD) contamination that they could be at risk of contracting vCJD; and if she will make a statement.

To ask the Secretary of State for Health what steps have been taken to inform those who received blood known to be at risk of variant Creutzfeldt-Jakob Disease (vCJD) contamination that they could be at risk of contracting vCJD; and if she will make a statement.

To ask the Secretary of State for Health when she expects to be in a position to make a decision on the steps her Department will take to reduce the risk of variant Creutzfeldt-Jakob Disease transmission via the transfusion of blood from asymptomatic carriers.

To ask the Secretary of State for Health when she expects to be in a position to make a decision on the steps her Department will take to reduce the risk of variant Creutzfeldt-Jakob Disease transmission via the transfusion of blood from asymptomatic carriers.

To ask the Secretary of State for Health whether a cost/benefit assessment of introducing prion removal blood filters to reduce the transmission of variant Creutzfeldt-Jakob Disease via blood transfusion has been undertaken by her Department; and if she will make a statement.

To ask the Secretary of State for Health whether a cost/benefit assessment of introducing prion removal blood filters to reduce the transmission of variant Creutzfeldt-Jakob Disease via blood transfusion has been undertaken by her Department; and if she will make a statement.

To ask the Secretary of State for Health what arrangements are in place for blood specimens held by the Blood Transfusion Service to be used in research to test for vCJD; and if she will make a statement.

To ask the Secretary of State for Health what arrangements are in place for blood specimens held by the Blood Transfusion Service to be used in research to test for vCJD; and if she will make a statement.

To ask the Secretary of State for Health how many requests her Department has received for blood specimens held by the Blood Transfusion Service to be used in research to test for vCJD; and if she will make a statement.

To ask the Secretary of State for Health how many requests her Department has received for blood specimens held by the Blood Transfusion Service to be used in research to test for vCJD; and if she will make a statement.

To ask the Secretary of State for Health what (a) tests and (b) prototype tests for the presence of vCJD in blood are (i) available and (ii) the subject of research; and if she will make a statement.

To ask the Secretary of State for Health what (a) tests and (b) prototype tests for the presence of vCJD in blood are (i) available and (ii) the subject of research; and if she will make a statement.

Adjournment debate on variant Creutzfeld-Jakob disease and endodontic instruments.

Adjournment debate on variant Creutzfeld-Jakob disease and endodontic instruments.

I shall say more about costs and further work later. The Department has now received some early findings from the Health Protection Agency from research on mice, which is still in progress. I will write to the hon. Gentleman with some of the details that he requested. The early findings...

I shall say more about costs and further work later. The Department has now received some early findings from the Health Protection Agency from research on mice, which is still in progress. I will write to the hon. Gentleman with some of the details that he requested. The early findings...